Effects of tolvaptan on physician-assessed signs and symptoms in patients admitted with acute heart failure - results from the EVEREST program

Mihai Gheorghiade; Peter S. Pang; John E. Blair; Karl Swedberg; Faı̈ez Zannad; Aldo Maggioni; L GRINFIELD; J. C. Burnett; Christopher Zimmer; Marvin A. Konstam

doi:10.1016/s1567-4215(08)60179-4

Back

Effects of tolvaptan on physician-assessed signs and symptoms in patients admitted with acute heart failure - results from the EVEREST program

Article 2008 en

Abstract

1 min read

267 Effects of tolvaptan on physician-assessed signs and symptoms in patients admitted with acute heart failure results from the EVEREST program M. Gheorghiade1, P. Pang1, J. Blair1, K. Swedberg2, F. Zannad3, A. Maggioni4, L. Grinfield5, J. Burnett6, C. Zimmer7, M. Konstam8 1Northwestern University, Internal Medicine/Cardiology, Chicago, United States of America; 2Sahlgrenska University Hospital, Gothenburg, Sweden; 3INSERM, Nancy, France; 4Associazione Nazionale Medici Cardioligi, Florence, Italy; 5Hospital Italiano, Buenos Aires, Argentina; 6Mayo Medical School, Rochester, United States of America; 7Otsuka Maryland Research Institute, Rockville, United States of America; 8Tufts Universtiy New England Medical Center, Boston, United States of America

Related publications

Article2008

Regional differences in baseline characteristics and outcomes in patients admitted with acute heart failure - results from the EVEREST program

John E. Blair, Faı̈ez Zannad, Marvin A. Konstam, Thomas D. Cook, John C. Burnett, L GRINFIELD, Aldo Maggioni, Karl Swedberg, James E. Udelson, Mihai Gheorghiade

Article2008

Prognostic value and changes in renal function in patients admitted with acute heart failure - results from the EVEREST program

John E. Blair, John C. Burnett, Marvin A. Konstam, Aldo Maggioni, Karl Swedberg, James E. Udelson, Faı̈ez Zannad, Thomas D. Cook, Gerasimos Filippatos, Mihai Gheorghiade

Article2008

Effects of Tolvaptan in Patients Hospitalized with Heart Failure and Renal Impairment and Hypotension in the EVEREST Trial

Peter S. Pang, Marvin A. Konstam, Faı̈ez Zannad, Aldo Maggioni, Karl Swedberg, Liliana Grinfeld, John C. Burnett, Holly B. Krasa, Christopher Zimmer, John E. Blair, John Ouyang, Mihai Gheorghiade

Article2009

Clinical characteristics, management, and prognosis of octogenarians with acute heart failure admitted to cardiology wards: Results from the Italian Survey on Acute Heart Failure

Daniela Miani, Claudio Fresco, Donata Lucci, Maria Cecilia Albanese, Lucio Gonzini, P. Fioretti, Aldo Maggioni, Luigi Tavazzi

Article2009

Effects of tolvaptan on dyspnoea relief from the EVEREST trials

Peter S. Pang, Marvin A. Konstam, H. B. Krasa, K. Swedberg, F. Zannad, John E. Blair, Christopher Zimmer, John R. Teerlink, Aldo Maggioni, John C. Burnett, L. Grinfeld, J. Ouyang, James E. Udelson, Mihai Gheorghiade

Effects of tolvaptan on physician-assessed signs and symptoms in patients admitted with acute heart failure - results from the EVEREST program

Abstract

Discussion(0)

Related publications

Regional differences in baseline characteristics and outcomes in patients admitted with acute heart failure - results from the EVEREST program

Prognostic value and changes in renal function in patients admitted with acute heart failure - results from the EVEREST program

Effects of Tolvaptan in Patients Hospitalized with Heart Failure and Renal Impairment and Hypotension in the EVEREST Trial

Clinical characteristics, management, and prognosis of octogenarians with acute heart failure admitted to cardiology wards: Results from the Italian Survey on Acute Heart Failure

Effects of tolvaptan on dyspnoea relief from the EVEREST trials